Skip to content

CLRB — Cellectar Biosciences Inc Institutional Holders · Q2 2026

Who owns Cellectar Biosciences Inc (CLRB)? 31 institutions reported holding $9.08M in SEC 13F filings for Q2 2026 (period ended 2026-06-30). Largest holders: Caligan Partners LP ($1.3M), Vanguard Group Inc ($1.0M), Stempoint Capital LP ($986,728).

RankInstitutionValueSharesChange
1Caligan Partners LP$1.3M469,998New
2VANGUARD GROUP INC$1.0M373,587Added
3STEMPOINT CAPITAL LP$986,728354,938New
4SILVERARC CAPITAL MANAGEMENT, LLC$894,404321,728New
5Bleichroeder LP$802,528288,679Added
6Jupiter Topco LLC$759,412274,156New
7Balyasny Asset Management L.P.$611,600220,000New
8Nantahala Capital Management, LLC$611,594219,998New
9Empery Asset Management, LP$527,102189,605New
10DIADEMA PARTNERS LP$384,588138,341New
11Stonepine Capital Management, LLC$290,649104,550New
12Persistent Asset Partners Ltd$258,49392,983New
13BOOTHBAY FUND MANAGEMENT, LLC$236,49285,069New
14GEODE CAPITAL MANAGEMENT, LLC$148,32353,351Added
15Sequoia Financial Advisors, LLC$60,74321,850Added
16Riverview Capital Advisers, LLC$50,05110,384Hold
17ACADIAN ASSET MANAGEMENT LLC$46,00016,577New
18NORTHERN TRUST CORP$41,25214,839New
19BlackRock, Inc.$13,1634,735Trimmed
20UBS Group AG$8,5993,093Trimmed
21BARCLAYS PLC$1,560561New
22MORGAN STANLEY$1,418510Hold
23TD Waterhouse Canada Inc.$17863Hold
24SBI Securities Co., Ltd.$3111Hold
25OSAIC HOLDINGS, INC.$187Added

Source: SEC Form 13F filings · as of 2026-06-30